Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Abdolrasool Esmailzadeh"'
Autor:
A. Comessatti, Yongsheng Wang, Xikun Zhou, Mary Kaye Willian, Pedram Yousefi, Selim Aractingi, Marie Pierre Boussuge, Sonia Sizto, Nick Bansback, Yuquan Wei, Paolo Broganelli, Gérald Pierard, Nongyu Huang, Huiying Sun, Carl Gebhardt, Lars E. French, Xiaolei Luo, Siegfried Segaert, Jan C. Simon, Kiarash Khosrotehrani, Stephan Schreml, Manisha Mehta, Xiancheng Chen, Nagayasu Egawa, Michael Landthaler, M. Novelli, Claude Bachmeyer, Philipp Babilas, Takuro Kanekura, Joseph Wajdula, Reinhard Dummer, P. Quaglino, Antonio Cozzio, Rolf-Markus Szeimies, Takashi Yao, C. Costa, P. Savoia, Caterina M. Giorgio, Laurence Paolozzi, Paul Duriez, Pascale Quatresooz, Iris Zalaudek, Giuseppe Argenziano, Aaron Fay, Steven R. Feldman, Koichi Suda, Abdolrasool Esmailzadeh, Aslam H. Anis, Gerardo Ferrara, Jiong Li, Cis Durian, Francis Berenbaum, Akira Ichikawa, Hidemi Takagi, Adriana Hernandez Salas, Kristian Reich, Susanne Gantner, Robert Boggs, Jacques Cosnes, M. Ortoncelli, S. Cicchelli, Giovanni Pellacani, R. Ponti, Carlo Tomasini, M. Bergallo, Peter C.M. van de Kerkhof, M.G. Bernengo, Tino Wetzig, Patrick A. Oberholzer, Günther F.L. Hofbauer, David Farhi, Xiaoxiao Ren, Kazuhiro Kawai, Julia Steinbauer, Peter Itin, Tohru Kiyono
Publikováno v:
Dermatology. 219:285-288
Autor:
Abdolrasool Esmailzadeh, Pedram Yousefi, Francis Berenbaum, Kiarash Khosrotehrani, David Farhi, Claude Bachmeyer, Jacques Cosnes, Selim Aractingi, Paul Duriez
Publikováno v:
Dermatology
Dermatology, Karger, 2009, 219 ((3)), pp.263-7. 〈10.1159/000235582〉
Dermatology, Karger, 2009, 219 ((3)), pp.263-7. ⟨10.1159/000235582⟩
Dermatology, 2009, 219 ((3)), pp.263-7. ⟨10.1159/000235582⟩
Dermatology, Karger, 2009, 219 ((3)), pp.263-7. 〈10.1159/000235582〉
Dermatology, Karger, 2009, 219 ((3)), pp.263-7. ⟨10.1159/000235582⟩
Dermatology, 2009, 219 ((3)), pp.263-7. ⟨10.1159/000235582⟩
Background: Anti-tumor-necrosis-factor-α agents are limited by their side effects. Eczema is one of the most frequent adverse reactions affecting quality of life. Objective: To assess potential predictive risk factors for eczema in patients receivin